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ABSTRACT
Background Utilisation of the electronic medical
record (EMR) is believed to facilitate timely access
to patient information, enhance communication
between care team members and further promote
clinical decision support.
Objective To determine if pharmacist-generated
electronic consults (e-consults) improve blood
pressure control among patients with uncontrolled
hypertension in a multisite health centre.
Methods Pharmacists generated hypertension med-
ication e-consults with review by primary care
provider (PCP) during the patient appointment.
We conducted a retrospective review of consults to
determine types of pharmacist recommendations,
PCP acceptance rates, and blood pressure changes.
Results Pharmacists generated a total of 60 e-
consults, 41 patients with a systolic blood pressure
above their respective goal; e-consults were ac-
cepted 46% (n = 19) of the time.
Conclusion This pilot project demonstrates a
unique way for pharmacists to proactively utilise
the EMRwhen delivering coordinated care within a
multisite health centre. In addition, pharmacists
were successfully integrated into the planned care
approach.
Keywords: electronic medical record, health centre,
health information technology, pharmacist
What is known about the subject?
. Electronic medical records facilitate real-time communication among care team members to promote
team-based care.
. Electronic medical records may help improve patient-oriented outcomes through care coordination and
planning.
. When focused on hypertension management, involvement of a clinical pharmacist can improve
medication adherence, blood pressure control and reduce overall medical costs.
What this study adds
This project demonstrates a unique way for pharmacists to participate in delivering multidisciplinary care
within a multisite health centre.
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Introduction
The patient-centred medical home (PCMH) is a
progressive model of care which focuses on providing
comprehensive primary care in a collaborative man-
ner. Key elements include a team approach that is
physician-directed and provides ongoing patient-
oriented care, focus on safety and quality, and incor-
poration of enhanced patient access to care through
inclusion of health information technology (HIT).1
Pharmacist involvement in delivering comprehensive
medication management ties into various aspects of
the PCMH principles. In addition, ample evidence
supports improved medication adherence rates and
patient outcomes, enhanced patient engagement and
reduced medical costs when pharmacists are involved
in multidisciplinary care teams.2,3
Two residency-trained, clinical pharmacists pro-
vide medication therapy management services in a
multisite statewide health centre and nationally recog-
nised PCMH. Healthcare services of the organisation
include comprehensive medical, behavioural and dental
care in primary care sites, homeless shelters, school-
based systems and mobile locations. The healthcare
organisation, including its home for underserved and
special populations, has practices located across the
state of Connecticut and serves over 130 000 patients
each year. However, despite 13 locations throughout
the state, each pharmacist has only one primary
practice site.
An organisation-wide review of blood pressure
control showed 45% of all patients diagnosed with
hypertension were not at a goal blood pressure of
 140/90mmHg or 130/80mmHg according to the
goals set forth by the seventh report of the Joint
National Committee on Prevention, Detection, Eval-
uation, and Treatment of High Blood Pressure (JNC-
7).4 Hypertension remains a crucial area of concern as
it is an independent risk factor for heart attack, stroke
and renal disease.4 Despite the availability of safe and
eﬀective medications, national data suggests that
nearly 35% of US adults with diagnosed hypertension
who take antihypertensive therapy do not achieve
their respective blood pressure goal.5
To overcome both treatment inertia and patient
disengagement with the healthcare system, a quality
improvement (QI) project was designed to improve
blood pressure control across the organisation through
the use of HIT. At the core of this QI initiative was the
development and utilisation of electronic medical
record (EMR)-generated scorecards and incorpor-
ation of pharmacist-generated electronic consults (e-
consults). Because the EMR is central to the PCMH
framework, it was hypothesised that utilisation of the
EMR would facilitate timely access to patient infor-
mation, enhance communication between care team
members and further promote clinical decision support.
Methods
Because the e-consult process was part of a pilot QI
initiative for hypertension management, each phar-
macist reviewed a preselected primary care provider’s
(PCP’s) patient panel; two PCPs participated in this
pilot initiative. The pharmacist and provider were not
always located at the same practice site. For this
initiative, pharmacists electronically received a weekly
computer-generated report that identiﬁed patients
with an upcoming appointment in the next week and
uncontrolled hypertension based on JNC-7 guide-
lines.4 Reports contained an 18-month average sys-
tolic blood pressure and diastolic blood pressure, last
systolic blood pressure and diastolic blood pressure,
date of appointment and PCP name. E-consults were
not generated for patients who achieved their blood
pressure goal.
The pharmacist utilised the EMR to review each
patient’s medical record. The process included review
of the patient’s medication regimen, laboratory meas-
ures, vital signs, lifestyle habits, education received
and, when necessary, a call to the patient’s pharmacy
to assess medication adherence. Following a compre-
hensive review, the pharmacist generated an e-consult
in the patient’s EMR. All components of the review
were documented, in addition to the pharmacist’s
assessment and pharmacological and non-pharmaco-
logical recommendations. The pharmacist sent the e-
consult to the PCP for review prior to the patient’s
appointment. During the visit, the PCP elected to
accept or decline the pharmacist’s recommendation(s).
We conducted a retrospective review of the existing
e-consults to determine types of recommendations,
PCP acceptance rate and change in blood pressure.
Owing to the study’s retrospective nature, no direct
contact between pharmacists and patients was made
in the data collection or analysis process. All patient
information was collected using password protected
software to assure compliance with the Health In-
surance Portability and Accountability Act (HIPAA)
of 1996. The project was exempt from full review by
the health centre’s institutional review board.
Results
Patient demographics and characteristics are in Table 1.
Using the EMR, pharmacists generated a total of 60 e-
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consults between September and December 2010. The
PCPs reviewed all submitted pharmacist e-consults
prior to the patient visit. Forty-one patients presented
to their scheduled oﬃce visit with a systolic blood
pressure above the respective goal of 140 mmHg or
 130 mmHg per clinical practice guidelines.4 Of the
41 patient encounters, the responsible PCP elected to
accept the pharmacologic recommendations proposed
by the pharmacist 19 times (46%). Recommendations
that were not accepted could be used at a future visit,
since all e-consults became a permanent part of the
patient’s EMR. Reasons for a declined recommen-
dation included, but were not limited to, patient
reports of medication non-adherence, other specialists
managing hypertension or patient refusal for ad-
ditional medication. Prior to the intervention period,
blood pressure control rates for the participating PCPs
were 59.73 and 56.68%. By December 2010, control
rates were 60.5 and 55.43%, respectively.
The pharmacists proposed a total of 67 pharma-
cotherapeutic recommendations for PCP consider-
ation, with an average of 1.1 recommendations per
patient. Figure 1 represents the types of drug therapy
recommendations suggested by the pharmacists. In
addition, the pharmacists suggested an additional 62
non-pharmacologic strategies, including education on
sodium restriction, adaption of the Dietary Approaches
to Stop Hypertension (DASH) diet and tobacco cess-
ation to name a few.
Discussion
With multiple locations across the state and two
clinical pharmacists within the organisation, utilis-
ation of HIT allows pharmacists to actively participate
in patient care coordination and planning. When
focused on hypertension management, involvement
of a clinical pharmacist has consistently demonstrated
improvements inmedication adherence, blood pressure
control and reduced overall medical costs.3,6,7 Rec-
ommendations made (by pharmacists) to physicians
and the use of hypertension treatment algorithms,
along with patient counselling about lifestyle modiﬁ-
cations, are considered the most eﬀective team-based
interventions.6 Compared with previous studies, our
pilot project demonstrates a unique and proactive way
for pharmacists to oﬀer medical expertise without
direct face-to-face contact with patients or medical
providers.
Although this was a proactive approach to provid-
ing clinical pharmacy services, the pharmacist’s evalu-
ation of the patient’s EMR took place prior to the
Table 1 Patient demographics and
characteristics
Baseline characteristics (n = 60)
Age (years) 55  13
Median 56
Interquartile range 16.75










Tobacco abuse, n (%) 12 (20)
Co-morbid diabetes, n (%) 35 (58)
BP goala, n (%)
 140/90 mmHg 20 (33)





 4 8 (14)
18-month BP average (mmHg)
Systolic 148  15
Diastolic 86  8
aAs indicated by the JNC-7 guidelines.4
Figure 1 Pharmacotherapy recommendations
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actual encounter. Subsequently, pharmacists relied
heavily on past blood pressure and average blood
pressure readings obtained from ﬂowsheets and pro-
gress notes when making recommendations. Current
blood pressure readings were not assessed by the
pharmacist in the e-consult, but rather by the PCP
during the patient encounter. Often, it was this
isolated blood pressure reading that largely inﬂuenced
if therapy would be added, discontinued, or modiﬁed.
Access to temporal data views as suggested by Samal
and colleagues may have oﬀered the pharmacists and
PCPs a more practical way to visualise blood pressure
trends andmake connections between blood pressures
and prior interventions.8 Variables, not clearly docu-
mented during retrospective chart evaluation, limited
the interpretation of recommendations; therefore,
collected data broadly categorises the types of phar-
macist recommendations.
With the prevalence of chronic disease on the rise,
coordinated interventions are needed to reduce death
rates and healthcare spending. In 2000, more than 125
million Americans had at least one chronic care con-
dition. By 2020, it is estimated to grow to 157 million
Americans.9 Identiﬁcation of high-risk patients in
need of treatment and preventative medicine begins
in primary care settings. Utilising an EMR facilitates
access to such information, while maintaining con-
ﬁdentiality, in order to deliver patient care.10 EMRs
also promote multidisciplinary, patient-centred care
through communication strategies beyond progress
notes.11 Our pilot demonstrated such a strategy through
specialist consultation in the form of e-consults. Spe-
ciﬁc to hypertension management, long-term evalu-
ation and spread of this programme is necessary to
assess the impact of pharmacist-generated e-consults
on blood pressure control.
Our practice innovation demonstrates a unique
way for pharmacists to proactively utilise HIT when
delivering coordinated, team-based care within a multi-
site health centre.
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